Global Retirement Partners’s Standard BioTools LAB Stock Holding History

Global Retirement Partners’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.99K	Buy	+4,851	New	+$4.58K	﹤0.01%	3767
2025 Q4	$16.6K	Buy	+12,967	New	+$17.4K	﹤0.01%	2942
2024 Q4	$1.54K	Hold	880	–	–	﹤0.01%	3165
2024 Q3	$1.7K	Hold	880	–	–	﹤0.01%	2991
2024 Q2	$1.56K	Hold	880	–	–	﹤0.01%	3053
2024 Q1	$2.38K	Hold	880	–	–	﹤0.01%	2680
2023 Q4	$2.07K	Hold	880	–	–	﹤0.01%	2660
2023 Q3	$1.85K	Hold	880	–	–	﹤0.01%	2566
2023 Q2	$1.7K	Hold	880	–	–	﹤0.01%	2603
2023 Q1	$1.32K	Buy	+880	New	+$1.74K	﹤0.01%	2640

Other funds holding LAB

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Global Retirement Partners's LAB Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Standard BioTools (LAB) in Q2 2026: 4,851 shares worth $3.99K. The stake represents ﹤0.01% of the portfolio and ranks #3767 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in LAB as recently as Q4 2025.

Global Retirement Partners first reported a position in LAB in Q1 2023 and has held it in 10 quarters since. The position peaked at $16.6K in Q4 2025. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

Global Retirement Partners held 4,851 shares of Standard BioTools worth $3.99K as of Q2 2026.
Standard BioTools was a new Global Retirement Partners position in Q2 2026.
Standard BioTools made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3767 holding.
Global Retirement Partners first reported a position in Standard BioTools in Q1 2023 and has held it in 10 quarters since.
Global Retirement Partners's Standard BioTools position peaked at $16.6K in Q4 2025.
143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.